1. The roles and mechanisms of hypoxia in liver fibrosis
- Author
-
Zhiyang Chen, Zeng Ling, Jingyao Cai, and Min Hu
- Subjects
0301 basic medicine ,Liver Cirrhosis ,Cirrhosis ,Carcinoma, Hepatocellular ,Liver fibrosis ,Review ,Bioinformatics ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Hypoxia ,Mechanism (biology) ,business.industry ,Liver Neoplasms ,General Medicine ,Hypoxia (medical) ,medicine.disease ,Fibrosis ,030104 developmental biology ,Liver ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Etiology ,Quality of Life ,Medicine ,Mechanism ,medicine.symptom ,business ,Chronic liver injury - Abstract
Liver fibrosis occurs in response to any etiology of chronic liver injury. Lack of appropriate clinical intervention will lead to liver cirrhosis or hepatocellular carcinoma (HCC), seriously affecting the quality of life of patients, but the current clinical treatments of liver fibrosis have not been developed yet. Recent studies have shown that hypoxia is a key factor promoting the progression of liver fibrosis. Hypoxia can cause liver fibrosis. Liver fibrosis can, in turn, profoundly further deepen the degree of hypoxia. Therefore, exploring the role of hypoxia in liver fibrosis will help to further understand the process of liver fibrosis, and provide the theoretical basis for its diagnosis and treatment, which is of great significance to avoid further deterioration of liver diseases and protect the life and health of patients. This review highlights the recent advances in cellular and molecular mechanisms of hypoxia in developments of liver fibrosis.
- Published
- 2021